Healthcare - Medical - Devices - NASDAQ - US
$ 75.88
1.61 %
$ 29.6 B
Market Cap
44.64
P/E
CASH FLOW STATEMENT
748 M
OPERATING CASH FLOW
-507 M
INVESTING CASH FLOW
-319 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
DexCom, Inc.
| Net Income | 542 M |
| Depreciation & Amortization | 186 M |
| Capital Expenditures | -237 M |
| Stock-Based Compensation | 151 M |
| Change in Working Capital | 3.2 M |
| Others | -541 M |
| Free Cash Flow | 512 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||||
| Net Income | 541.5 | 341.2 | 154.7 | 493.6 | 101.1 | (127.1) | (50.2) | (65.6) | (57.6) | (22.4) | (29.8) | (54.5) | (44.7) | (55.2) | (53.5) | (55.2) | (45.9) | (46.6) | (30.8) | (13.9) | (9.9) |
| Depreciation & Amortization | 186.0 | 155.9 | 102.0 | 67.1 | 48.7 | 29.1 | 16.1 | 15.0 | 10.8 | 8.4 | 7.0 | 6.6 | 3.8 | 2.4 | 2.4 | 3.6 | 3.3 | 2.7 | 1.1 | 0.9 | 0.4 |
| Deferred Income Tax | (55.0) | (21.6) | (4.9) | (277.3) | 4.2 | (80.1) | 0 | 1.3 | 0.3 | 0.3 | 0.3 | (1.3) | 32.2 | (0.8) | (8.1) | (7.7) | (6.1) | (5 852.9) | (1 665.6) | 0 | 0 |
| Stock Based Compensation | 150.8 | 126.5 | 113.4 | 119.4 | 102.7 | 101.9 | 106.2 | 110.8 | 82.7 | 50.0 | 24.6 | 18.4 | 13.5 | 9.4 | 8.4 | 7.7 | 6.1 | 5 852.9 | 1 665.6 | 0 | 0 |
| Other Operating Activities | (78.0) | 39.8 | 209.3 | 93.6 | 51.7 | 240.3 | 17.3 | 1.0 | 37.2 | 100 K | 3.1 | 1.6 | (31.2) | 11.2 | 13.8 | 8.0 | 5.6 | 5.5 | 1.8 | 29.9 K | 0 |
| Change in Working Capital | 3.2 | 27.7 | (132.0) | (20.8) | 6.1 | (40.9) | 2.6 | (6.3) | (24.4) | (12.8) | (2.8) | (3.9) | (3.6) | (9.8) | (2.2) | 6.1 | 3.7 | (5.3) | 5.4 | 0.6 | 99.3 K |
| Cash From Operations | 748.5 | 669.5 | 442.5 | 475.6 | 314.5 | 123.2 | 92.0 | 56.2 | 49.0 | 23.6 | 2.4 | (33.1) | (30.1) | (42.7) | (39.4) | (37.5) | (33.2) | (43.7) | (22.6) | (12.4) | (9.5) |
| INVESTING CASH FLOW | |||||||||||||||||||||
| Capital Expenditures | (236.6) | (364.8) | (389.2) | (199.0) | (180.0) | (67.1) | (66.0) | (55.7) | (33.3) | (16.2) | (7.9) | (9.5) | (8.0) | (6.9) | (3.0) | (2.5) | (3.4) | (3.4) | (4.7) | (1.8) | (0.4) |
| Other Items | (270.6) | (156.7) | 173.1 | (819.0) | (835.2) | (72.7) | (78.4) | (0.2) | (18.2) | (0.6) | 28.8 | 37.9 | (38.4) | (18.8) | (11.1) | 26.8 | (5.0) | (23.2) | (13.5) | 20.1 K | 7.8 |
| Cash From Investing Activities | (507.2) | (521.5) | (216.1) | (1 018.0) | (1 015.2) | (139.8) | (144.4) | (55.9) | (51.5) | (16.8) | 20.9 | 28.4 | (46.4) | (25.6) | (14.1) | 24.3 | (8.4) | (26.6) | (18.2) | (1.7) | 7.4 |
| FINANCING CASH FLOW | |||||||||||||||||||||
| Common Stock Repurchased | (688.7) | (557.7) | 0 | 0 | 0 | (100.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (2.7) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 443.3 | 0 | 0 | 906.2 | 0 | 836.6 | 389.0 | (2.3) | (2.3) | (2.2) | (0.2) | 6.6 | (0.5) | (0.9) | (1.9) | 0.9 | 48.4 | 3.0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (99.8) | (17.3) | (9.9) | (9.4) | (1.2) | (37.0) | 0 | 0 | 0 | 0 | 0 | 0 | 16 K | 46 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Financing Activities | (318.6) | (552.5) | 10.4 | 912.1 | 10.7 | 710.4 | 399.1 | 8.1 | 16.8 | 21.8 | 11.8 | 10.2 | 74.2 | 69.6 | 44.4 | 2.7 | 46.6 | 51.2 | 50.7 | 21.4 | 33.4 K |
| CHANGE IN CASH | |||||||||||||||||||||
| Net Change In Cash | (75.8) | (410.3) | 235.4 | 371.8 | (690.7) | 695.6 | 347.0 | 8.4 | 14.3 | 28.6 | 35.1 | 5.5 | (2.3) | 1.3 | (9.1) | (10.4) | 4.9 | (19.1) | 10.0 | 7.2 | (2.1) |
| FREE CASH FLOW | |||||||||||||||||||||
| Free Cash Flow | 511.9 | 304.7 | 53.3 | 276.6 | 134.5 | 56.1 | 26.0 | 0.5 | 15.7 | 7.4 | (5.5) | (42.6) | (38.1) | (49.5) | (42.4) | (39.9) | (36.6) | (47.1) | (27.2) | (14.2) | (9.9) |